These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14284144)

  • 41. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cervical Ectropion and Intra-Uterine Contraceptive Device (IUCD): a five-year retrospective study of family planning clients of a tertiary health institution in Lagos Nigeria.
    Wright KO; Mohammed AS; Salisu-Olatunji O; Kuyinu YA
    BMC Res Notes; 2014 Dec; 7():946. PubMed ID: 25539789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Histological and cytological changes in women using intrauterine contraceptive devices (author's transl)].
    Poppendiek G; Dallenbach-Hellweg G; Hettenbach A
    Geburtshilfe Frauenheilkd; 1980 Aug; 40(8):716-21. PubMed ID: 7409431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device.
    Goldstuck ND; Matthews ML
    Clin Reprod Fertil; 1985 Mar; 3(1):65-71. PubMed ID: 3978537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of immunofluorescence and culture for the detection of Actinomyces israelii in wearers of intra-uterine contraceptive devices.
    Leslie DE; Garland SM
    J Med Microbiol; 1991 Oct; 35(4):224-8. PubMed ID: 1941993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
    Elhag KM; Bahar AM; Mubarak AA
    J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
    Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
    J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [ON THE RIBONUCLEIC ACID AND PROTEIN CONTENT IN STRATIFIED SQUAMOUS EPTHELIUM IN PRECANCEROUS CONDITIONS OF THE UTERINE CERVIX].
    NIKITIN AI
    Akush Ginekol (Mosk); 1964; 40():67-71. PubMed ID: 14248260
    [No Abstract]   [Full Text] [Related]  

  • 51. [Epidemiologic study of cervico-vaginal pathology in IUD users].
    Mossa B; Marziani R; Galeano C; Magnanti G; Domenici R
    Minerva Ginecol; 1993; 45(1-2):27-30. PubMed ID: 8469361
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PREGNANCY OCCURRING IN THE PRESENCE OF AN INTRAUTERINE CONTRACEPTIVE DEVICE. A REPORT OF TWO CASES.
    KWEE E
    Singapore Med J; 1964 Jun; 4():88-90. PubMed ID: 14192688
    [No Abstract]   [Full Text] [Related]  

  • 53. Association of amoebae and actinomyces in an intrauterine contraceptive device user.
    Arroyo G; Quinn JA
    Acta Cytol; 1989; 33(3):298-300. PubMed ID: 2728783
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of intrauterine device in the setting of uterus didelphys.
    Espey E; Ogburn T; Hall R; Byrn F
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):774-6. PubMed ID: 17018498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The effect of two contraceptive methods (EP vs. IUD) in relation to inflammatory changes and CIN].
    Cipolla L; Manzi P; Giannetta G; Ferrante B; Zagni R
    Minerva Ginecol; 1993 Jun; 45(6):315-20. PubMed ID: 8355888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of a smart IUD launcher for prevention of uterine perforation.
    Al-Ashwal RH; Aziz NA; Nooh SM
    Biomed Tech (Berl); 2016 Oct; 61(5):551-556. PubMed ID: 26913452
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [COLPOSCOPIC, CYTOLOGIC AND HISTOLOGIC FINDINGS IN THE PORTIO UTERI DURING OVULATION INHIBITING MEDICATION].
    GUHR O
    Munch Med Wochenschr; 1965 Mar; 107():485-9. PubMed ID: 14266625
    [No Abstract]   [Full Text] [Related]  

  • 58. Electrical activity of the human uterus in the presence of intrauterine contraceptive device.
    Serr DM; Mannor SM; Zakut H
    Obstet Gynecol; 1970 Feb; 35(2):217-20. PubMed ID: 5414208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pelvic actinomycosis and usage of intrauterine contraceptive devices.
    Kelly J; Aaron J
    Yale J Biol Med; 1982; 55(5-6):453-61. PubMed ID: 7183022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics of the uterine mucosa in cervix dysplasia].
    Kukuté BG
    Vopr Onkol; 1979; 25(3):3-6. PubMed ID: 433200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.